Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G Replimune Group, Inc. Filed by: Ridgeback Capital Investments L.P.

May 21, 2026 5:24 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The percentages used herein are calculated based upon 82,572,619 shares of common stock outstanding as of January 30, 2026, as reported by the Company in its Quarterly Report on Form 10-Q filed with the SEC on February 3, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentages used herein are calculated based upon 82,572,619 shares of common stock outstanding as of January 30, 2026, as reported by the Company in its Quarterly Report on Form 10-Q filed with the SEC on February 3, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentages used herein are calculated based upon 82,572,619 shares of common stock outstanding as of January 30, 2026, as reported by the Company in its Quarterly Report on Form 10-Q filed with the SEC on February 3, 2026.


SCHEDULE 13G



Ridgeback Capital Investments L.P.
Signature:/s/ Nicole Venezia
Name/Title:Nicole Venezia/General Counsel
Date:05/21/2026
Ridgeback Capital Investments LLC
Signature:/s/ Nicole Venezia
Name/Title:Nicole Venezia/General Counsel
Date:05/21/2026
Ridgeback Capital Management LLC
Signature:/s/ Nicole Venezia
Name/Title:Nicole Venezia/General Counsel
Date:05/21/2026
Exhibit Information

Exhibit Number 99.1 - Joint Filing Agreement

ATTACHMENTS / EXHIBITS

EXHIBIT 99.1

Categories

SEC Filings